North America Still Provides The Best Opportunities For Investors in Pharmaceutical Drugs Market

Growth/share Chart On Global Pharmaceutical Drugs Market. North America Provides The Best Opportunities For Investors In Pharmaceuticals Market

LONDON, GREATER LONDON, UK, August 21, 2017 /EINPresswire.com/ -- North America’s medical drug habit continues to make it one of the world’s most attractive markets. Despite regulatory and funding change and its already high per capita spend, the continent is still one of the best places to invest in the pharmaceuticals industry. North America is the largest region in the pharmaceutical drugs market. It also shows a strong growth with 5% growth rate in the forecast period according to the latest report “Pharmaceutical Drugs Market Global Report 2017” by The Business Research Company (TBRC). Among all the regions the pharmaceutical drugs market provides the best opportunity for investments in North America. The market already boasts considerable scale being valued at more than $300 billion, but it is expected to grow with 5% growth rate. The market is already highly exploited with an average spend of $675 on pharmaceutical drugs per capita , which is 1.5 and 4 times higher than the average spend per capita in the Western and Eastern Europe regions respectively, and almost 15 times higher than the average spend per capita in the Asia Pacific region. TBRC expects the market to grow further in the next five years.
The pharmaceutical industry develops drugs to diagnose, cure, and treat or prevent diseases. Pharmaceutical companies produce both generic and branded drugs. They are subjected to various laws and regulations that deal with patenting, testing, safety, efficacy and marketing.
The highest growth in the pharmaceuticals drugs market is expected to show in Asia Pacific region. The region was already valued at close to $200 billion in 2016 and it is expected to grow at 8.4% growth rate. TBRC expects the pharmaceutical drugs market in the region to reach to $255 billion by 2020. Development of Asia based drug makers companies into the region and private healthcare providers are expected to continue the growth pattern in the market. Additionally, Japan will continue fueling the growth of the pharmaceutical drugs market in Asia Pacific region with comparatively high drug prices in the market.
Other good opportunities in the market are provided by North America and Western Europe regions. North America held the biggest pharmaceutical drugs market among all other regions in 2016 valued at more than $300 billion. TBRC expects this region to grow at 5% growth rate. On the other side the market in the Western Europe region was valued at more than $150 billion in 2016 and is expected to grow at 3.6% growth rate. The growth in both regions can be explained by North America and Western Europe holding the first and third biggest healthcare markets by region according to “Healthcare Market Global Report 2017”.
In the report The Business Research Company recommends to increase the level of merger deals across the pharmaceutical industry to sustain companies in the increasingly competitive pharmaceutical market. Following this strategy companies will be able to develop innovative products, services and solutions as well as sharing skills and expertise. For example, Abbvie announced collaboration with Google-backed life sciences firm Calico for establishing a research and development facility for the discovery of drugs and development of therapies for patients with age-related diseases, such as cancer.

WHERE TO LEARN MORE?
Read Pharmaceutical Drugs Market Global Report 2017 from The Business Research Company for information on the following:
Markets Covered: Cardiovascular Disorders, Dermatology, Gastrointestinal Diseases, Genito-Urinary Disorders, Hematology, Infectious Diseases, Metabolic Disorders, Musculoskeletal Disorders, Central Nervous System, Oncology, Ophthalmology, Respiratory Diseases
Companies Mentioned: Johnson & Johnson, Novartis AG, F. Hoffmann-La Roche Ltd, Pfizer Inc., and Sanofi
Countries: Brazil, China, France, Germany, India, Italy, Japan, Spain, Russia, UK, USA and Australia.
Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East And Africa
Time series: Five years historic and forecast.
Data: Ratios of market size and growth to related markets, GDP, Expenditure Per Capita, The Pharmaceutical Drugs Indicators Comparison.
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

About The Business Research Company
Visit TheBusinesResearchCompany.com. The Business Research Company is a market research and intelligence company which excels in company, market and consumer research. It has research professionals at its office in the UK, India, and the US as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology. The Business Research Company’s management have more than 20 years of varied business research experience. They have delivered hundreds of research projects to the senior management of some of the world’s largest organizations. The Business Research Company’s Consultant have master’s qualifications from top institutes and include MBAs, MSCs, CFAs and CAs. The Business Research Company’s Consultants gain training and qualifications from the market Research Society and are trained in advanced research practices, techniques, and ethics.

Oliver Guirdham
The Business Research Company
+44 744 3439350
email us here

Visit Company Website

Distribution channels: Banking, Finance & Investment Industry, Business & Economy, Healthcare & Pharmaceuticals Industry, World & Regional

EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.

Submit your press release